ArticleBiomedical signal processing and control2023
Weakly supervised segmentation of COVID-19 infection with local lesion coherence on CT images.
Article in Biomedical signal processing and control, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Refining weak supervision for robust lung cavity segmentation: A graph-affinity method with boundary constraints.PloS one · 2026Article
- Weakly-Supervised Segmentation-Based Quantitative Characterization of Pulmonary Cavity Lesions in CT Scans.IEEE journal of translational engineering in health and medicine · 2024Article
- Semi-supervised COVID-19 volumetric pulmonary lesion estimation on CT images using probabilistic active contour and CNN segmentation.Biomedical signal processing and control · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
At the end of 2019, a novel coronavirus, COVID-19, was ravaging the world, wreaking havoc on public health and the global economy. Today, although Reverse Transcription-Polymerase Chain Reaction (RT-PCR) is the gold standard for COVID-19 clinical diagnosis, it is a time-consuming and labor-intensive procedure. Simultaneously, an increasing number of individuals are seeking for better alternatives to RT-PCR. As a result, automated identification of COVID-19 lung infection in computed tomography (CT) images may help traditional diagnostic approaches in determining the severity of the disease. Unfortunately, a shortage of labeled training sets makes using AI deep learning algorithms to accurately segregate diseased regions in CT scan challenging. We design a simple and effective weakly supervised learning strategy for COVID-19 CT image segmentation to overcome the segmentation issue in the absence of adequate labeled data, namely LLC-Net. Unlike others weakly supervised work that uses a complex training procedure, our LLC-Net is relatively easy and repeatable. We propose a Local Self-Coherence Mechanism to accomplish label propagation based on lesion area labeling characteristics for weak labels that cannot offer comprehensive lesion areas, hence forecasting a more complete lesion area. Secondly, when the COVID-19 training samples are insufficient, the Scale Transform for Self-Correlation is designed to optimize the robustness of the model to ensure that the CT images are consistent in the prediction results from different angles. Finally, in order to constrain the segmentation accuracy of the lesion area, the Lesion Infection Edge Attention Module is used to improve the information expression ability of edge modeling. Experiments on public datasets demonstrate that our method is more effective than other weakly supervised methods and achieves a new state-of-the-art performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.